Yan Song

Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end‐stage renal disease on hemodialysis

Xiaoli Wang, Giridhar Tirucherai, Thomas Marbury et al. · The Journal of Clinical Pharmacology · 2015 · 280 citations · Full text

Healthy Subjects, Dialysis Therapy, Pharmacotherapy +19

MRSA epidemic linked to a quickly spreading colonization and virulence determinant

Min Li, Xin Du, Amer E. Villaruz et al. · Nature Medicine · 2012 · 276 citations · Full text

Pathogen Transmission, Pathogenesis, Disease Emergence +8

Essential Staphylococcus aureus toxin export system

Som S. Chatterjee, Hwang‐Soo Joo, Anthony C. Duong et al. · Nature Medicine · 2013 · 176 citations · Full text

Microbial Toxin, Medical Microbiology, Toxinology +4

Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor<scp>X</scp>a inhibitor

Charles Frost, Wonkyung Byon, Yan Song et al. · British Journal of Clinical Pharmacology · 2014 · 158 citations · Full text

A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban

Charles Frost, Yan Song, Yu Chen Barrett et al. · Clinical Pharmacology Advances and Applications · 2014 · 117 citations · Full text